投资评级与目标价 - Evercore ISI将Envista (NVST) 列入“战术跑赢大盘”名单 [1] - 公司对Envista维持“跑赢大盘”评级 [1] - 公司对Envista设定的目标股价为25美元 [1] 研究背景 - 该评级调整发生在第三季度财报季之前 [1] - 公司更新了预估并对医疗保健技术与分销板块做出了多项战术性判断 [1]

Evercore ISI analyst Elizabeth Anderson added Omada Health (OMDA) to the firm’s “Tactical Outperform” list as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season. The firm keeps an Outperform rating and $27 price target on Omada shares. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confi ...